Retiform purpura as a dermatological sign of coronavirus disease 2019 (COVID-19) coagulopathy

J Eur Acad Dermatol Venereol. 2020 Oct;34(10):e548-e549. doi: 10.1111/jdv.16689. Epub 2020 Jun 26.

Authors

X Bosch-Amate¹, P Giavedoni¹, S Podlipnik¹, C Andreu-Febrer¹, J Sanz-Beltran¹, A Garcia-Herrera², L Alós², J M Mascaró¹

Affiliations

¹ Department of Dermatology, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.
² Department of Pathology, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Anticoagulants / administration & dosage
Biopsy, Needle
Blood Coagulation Disorders / diagnosis
Blood Coagulation Disorders / drug therapy*
Blood Coagulation Disorders / pathology*
COVID-19
COVID-19 Testing
Clinical Laboratory Techniques
Coronavirus Infections / diagnosis
Coronavirus Infections / pathology*
Diagnosis, Differential
Emergency Service, Hospital
Female
Fluorescent Antibody Technique, Direct
Humans
Immunohistochemistry
Leg Dermatoses / diagnosis
Leg Dermatoses / drug therapy
Leg Dermatoses / pathology*
Pandemics
Pneumonia, Viral / diagnosis
Pneumonia, Viral / pathology*
Purpura / diagnosis
Purpura / pathology
Risk Assessment
Treatment Outcome

Substances

Anticoagulants